159 related articles for article (PubMed ID: 26116599)
1. Laboratory and Clinical features of EIA Toxin-positive and EIA Toxin-negative Community-acquired Clostridium difficile Infection.
Patel H; Randhawa J; Nanavati S; Marton LR; Baddoura WJ; DeBari VA
Ann Clin Lab Sci; 2015; 45(3):333-9. PubMed ID: 26116599
[TBL] [Abstract][Full Text] [Related]
2. Toxin positivity and tcdB gene load in broad-spectrum Clostridium difficile infection.
Kim HN; Kim H; Moon HW; Hur M; Yun YM
Infection; 2018 Feb; 46(1):113-117. PubMed ID: 29218569
[TBL] [Abstract][Full Text] [Related]
3. Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.
Erb S; Frei R; Strandén AM; Dangel M; Tschudin-Sutter S; Widmer AF
Clin Microbiol Infect; 2015 Nov; 21(11):998.e9-998.e15. PubMed ID: 26232535
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infection.
Baker I; Leeming JP; Reynolds R; Ibrahim I; Darley E
J Hosp Infect; 2013 Aug; 84(4):311-5. PubMed ID: 23831282
[TBL] [Abstract][Full Text] [Related]
5. Comparison of testing approaches for Clostridium difficile infection at a large community hospital.
Grein JD; Ochner M; Hoang H; Jin A; Morgan MA; Murthy AR
Clin Microbiol Infect; 2014 Jan; 20(1):65-9. PubMed ID: 23521523
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.
Kwon JH; Reske KA; Hink T; Burnham CA; Dubberke ER
J Clin Microbiol; 2017 Feb; 55(2):596-605. PubMed ID: 27927930
[TBL] [Abstract][Full Text] [Related]
7. Comparison of enzyme immunoassays and rapid diagnostic tests for clostridium difficile glutamate dehydrogenase and toxin a + B to toxinogenic culture on a highly selective chromogenic medium.
Olling A; Leidinger H; Hoffmann R
Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1655-9. PubMed ID: 27323765
[TBL] [Abstract][Full Text] [Related]
8. A two-stage algorithm for Clostridium difficile including PCR: can we replace the toxin EIA?
Orendi JM; Monnery DJ; Manzoor S; Hawkey PM
J Hosp Infect; 2012 Jan; 80(1):82-4. PubMed ID: 22104474
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes and treatment necessity in patients with toxin-negative Clostridioides difficile stool samples.
Cho DH; Kim SH; Jeon CH; Kim HT; Park KJ; Kim J; Kwak J; Kwan BS; Kong S; Lee JW; Kim KM; Wi YM
Ann Clin Microbiol Antimicrob; 2024 Apr; 23(1):35. PubMed ID: 38664689
[TBL] [Abstract][Full Text] [Related]
10. High proportion of false-positive Clostridium difficile enzyme immunoassays for toxin A and B in pediatric patients.
Toltzis P; Nerandzic MM; Saade E; O'Riordan MA; Smathers S; Zaoutis T; Kim J; Donskey CJ
Infect Control Hosp Epidemiol; 2012 Feb; 33(2):175-9. PubMed ID: 22227987
[TBL] [Abstract][Full Text] [Related]
11. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.
Goldenberg SD; Cliff PR; Smith S; Milner M; French GL
J Hosp Infect; 2010 Jan; 74(1):48-54. PubMed ID: 19900734
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification.
Bamber AI; Fitzsimmons K; Cunniffe JG; Beasor CC; Mackintosh CA; Hobbs G
Br J Biomed Sci; 2012; 69(3):112-8. PubMed ID: 23057158
[TBL] [Abstract][Full Text] [Related]
13. Searching for a Potential Algorithm for Clostridium difficile Testing at a Tertiary Care Hospital: Does Toxin Enzyme Immunoassay Testing Help?
Theiss AM; Balla A; Ross A; Francis D; Wojewoda C
J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743303
[No Abstract] [Full Text] [Related]
14. Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin.
Guerrero DM; Chou C; Jury LA; Nerandzic MM; Cadnum JC; Donskey CJ
Clin Infect Dis; 2011 Aug; 53(3):287-90. PubMed ID: 21765078
[TBL] [Abstract][Full Text] [Related]
15. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
Humphries RM; Uslan DZ; Rubin Z
J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile infection diagnostics - evaluation of the C. DIFF Quik Chek Complete assay, a rapid enzyme immunoassay for detection of toxigenic C. difficile in clinical stool samples.
Johansson K; Karlsson H; Norén T
APMIS; 2016 Nov; 124(11):1016-1020. PubMed ID: 27651167
[TBL] [Abstract][Full Text] [Related]
17. Can a toxin gene NAAT be used to predict toxin EIA and the severity of
Garvey MI; Bradley CW; Wilkinson MAC; Holden E
Antimicrob Resist Infect Control; 2017; 6():127. PubMed ID: 29270290
[TBL] [Abstract][Full Text] [Related]
18. Clostridium difficile colitis: an efficient clinical approach to diagnosis.
Manabe YC; Vinetz JM; Moore RD; Merz C; Charache P; Bartlett JG
Ann Intern Med; 1995 Dec; 123(11):835-40. PubMed ID: 7486465
[TBL] [Abstract][Full Text] [Related]
19. Repeat stool testing to diagnose Clostridium difficile infection using enzyme immunoassay does not increase diagnostic yield.
Deshpande A; Pasupuleti V; Patel P; Ajani G; Hall G; Hu B; Jain A; Rolston DD
Clin Gastroenterol Hepatol; 2011 Aug; 9(8):665-669.e1. PubMed ID: 21635969
[TBL] [Abstract][Full Text] [Related]
20. Two-stage algorithm for Clostridium difficile: glutamate-dehydrogenase-positive toxin-negative enzyme immunoassay results may require further testing.
Bignardi GE; Hill K; Berrington A; Settle CD
J Hosp Infect; 2013 Apr; 83(4):347-9. PubMed ID: 23399483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
